HUGE: FSD Pharma Company Short-Term Debt

Symbol and logo of brand fsdpharma.com (HUGE)

FSD Pharma Inc. (HUGE) is expanding its influence in the therapy of nervous system disorders through partnerships with biolabs to accelerate the testing of new molecules. This daily price action reflects a metric value of 0.00. The business relies on external contractors for formula development and testing, while the production of neuroprotective substances is fully outsourced to third-party plants.

HUGE (fsdpharma.com) Company Short-Term Debts history from 07/04/2022 to 08/15/2024

Financial and market metric breakdowns for FSD Pharma, Inc. (HUGE)

- current quotes and average value forecast:
Price Chart FSD Pharma|HUGE - Fair Value Consensus
- market capitalization information:
Market Value FSD Pharma Inc.|HUGE - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share FSD Pharma|HUGE - Book Capitalization|Market Cap to Net Assets Ratio fsdpharma.com|HUGE - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity FSD Pharma Inc.|HUGE - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital FSD Pharma Inc.|HUGE - Company Cumulative Debt|Debt to Book Value FSD Pharma Inc.|HUGE - Company Long-Term Debts|Company Short-Term Debt FSD Pharma|Quick Liquidity fsdpharma.com
- net income and valuation multiples indicators:
HUGE - Company Net Income
Basic company analysis:FSD Pharma - HUGE
Mass-produced product of FSD Pharma, Inc.

Short-term debt measures a company's obligations with a maturity of up to one year, reflecting working capital dynamics and reliance on external financing. When analyzing a company's short-term loans and borrowings, it is essential for an investor to distinguish between productive expansion financing and liquidity risk, which is critical for FSD Pharma (HUGE) during the development of costly biologics for the treatment of neurodegenerative diseases prior to entering the insurance fund market.

Competitors of FSD Pharma Inc. (HUGE)

JAZZ - Company Short-Term Debt|Company Short-Term Loans and Borrowings CYTK (Cytokinetics Inc.)|PTC Therapeutics Corp (PTCT) - Company Short-Term Debt|Company Current Liabilities Scholar Rock Inc.|CNTA (Centessa Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts dyne-tx.com|Company Current Liabilities EWTX (Edgewise Therapeutics, Inc.)|RAPP (Rapport Therapeutics Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Alumis Corp ALMS|ZVRA: Company Short-Term Indebtedness|Contineum Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt larimartx.com|CAPR (capricor.com) - Company Current Liabilities|Entrada Therapeutics Inc. (TRDA) - Company Short-Term Debts|Company Short-Term Debt Channel|MNOV: Company Short-Term Loans and Borrowings|Company Short-Term Debt Serina Therapeutics, Inc. (SER)|BTAI - Short-Term Debt|Company Short-Term Debt ProMIS Neurosciences, Inc. PMN|Apimeds Pharmaceuticals, Inc. - Company Short-Term Debt|AEON - Company Short-Term Debt|Short-Term Debt NLS Pharmaceutics AG|BNOX: Company Short-Term Debts|Short-Term Indebtedness reatapharma.com RETA